MedTrace Logo

Diclophenac Versus Placebo for Pain Control in Diagnostic Colonoscopy

NCT02339428 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2016-10-26

No results posted yet for this study

Summary

Patients will be randomized to receive diclophenac sodium or placebo two hours before diagnostic colonoscopy. Intensity of pain as measured on a 10-point Likert scale will be the primary outcome. Patients will be followed until hospital discharge, an average of 10 days.

Conditions

Interventions

DRUG

diclophenac sodium

Patients will be given 100mg p.o. diclophenac sodium tablets

DRUG

Placebo

Inactive pill manufactured to mimic diclofenac tablet

Sponsors & Collaborators

  • University Hospital Rijeka

    lead OTHER

Principal Investigators

  • Vanja Giljaca, MD, PhD · University Hospital Center Rijeka

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Croatia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02339428 on ClinicalTrials.gov